Delivery Order SPE2DB22D3004-SPE2DB25FSE39
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,137.07 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, awarded on July 23, 2025, with a completion date of July 24, 2025, utilizes firm fixed pricing with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors valued at $14,646.60. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,964.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, which carries an ultimate completion date of September 11, 2025, represents a competitively awarded, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $2,380.11 delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injectors on June 2, 2025, with completion scheduled for June 3, 2025. This non-competitive, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors with a ceiling value of $2,299.66. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the established pharmaceutical distributor. The delivery order is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, and is scheduled for completion by September 19, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors with a ceiling value of $2,115.21. The order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a firm fixed-price transaction with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,522.48 to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector, a migraine treatment medication. This firm fixed-price, non-set-aside contract was awarded on June 25, 2025, with an ultimate completion date of June 26, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors with a ceiling value of $1,411.51. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. Sumatriptan is a migraine treatment...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,554.79 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This firm fixed-price contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,572.84 to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector supplies. The contract is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and was awarded on July 30, 2025. This award is non-set-aside and represents a competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSE39Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,615.55 to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector supplies on August 26, 2025, with completion scheduled for August 27, 2025. This contract utilizes firm fixed-price pricing and was competitively awarded without set-aside restrictions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 master contract vehicle extending through December 2026 that provides comprehensive pharmaceutical and medical supply support for global military healthcare programs. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet competitive procurement requirements through the DLA Medical Supply Chain. Sumatriptan, a migraine treatment medication, represents a specialized pharmaceutical commodity within the company's broader offering of neurological and pain management products to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/26/25 |